2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action
ETA · 2024 · Europe
Source and licence
- Authors
- Luca Persani, Patrice Rodien, Carla Moran et al.
- Title
- 2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action
- Journal
- European Thyroid Journal, 2024
- Licence
- CC BY 4.0
- Changes
- Verbatim excerpts; formatting adapted
Full text retrieved 2026-10-27 from Europe PMC · PMC11301568
Licence statement of the original publication
This work is licensed under a Creative Commons Attribution 4.0 International License.
This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.
Open the original publication →Full text on Europe PMC
Recommendations
We found no explicitly labelled recommendations in this publication; its recommendations are in the running text of the original.
Abstract
Impaired sensitivity to thyroid hormones encompasses disorders with defective transport of hormones into cells, reduced hormone metabolism, and resistance to hormone action. Mediated by heritable single-gene defects, these rare conditions exhibit different patterns of discordant thyroid function associated with multisystem phenotypes. In this context, challenges include ruling out other causes of biochemical discordance, making a diagnosis using clinical features together with the identification of pathogenic variants in causal genes, and managing these rare disorders with a limited evidence base. For each condition, the present guidelines aim to inform clinical practice by summarizing key clinical features and useful investigations, criteria for molecular genetic diagnosis, and pathways for management and therapy. Specific, key recommendations were developed by combining the best research evidence available with the knowledge and clinical experience of panel members, to achieve a consensus.
Contents of the original publication
The section headings of the original.
- Introduction
- Methodology and grading of evidence
- Differential diagnosis of raised thyroid hormones and non-suppressed TSH
- Resistance to thyroid hormone β
- Diagnosis
- Clinical features
- Thyroid
- Cardiovascular phenotype
- Metabolism
- Neurological and audiovisual phenotypes
- Fertility and pregnancy
- Genotype-phenotype correlation
- Treatment of RTHβ
- Areas of uncertainty
- Resistance to thyroid hormone α
- Clinical features and making a diagnosis
- Management and treatment
- Areas of uncertainty
- Monocarboxylate transporter 8 deficiency
- Clinical features
- Making a diagnosis
- Management and treatment
- Areas of uncertainty and challenges
- Selenoprotein deficiency
- Background
- Diagnosis, management and treatment
- Areas of uncertainty
- Iodothyronine deiodinase defects
- Background
- Management
- Areas of uncertainty
- Supplementary Materials
A question about this guideline?
Medelix answers clinical questions from guidelines and studies – every statement with its source.
Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint